More drug companies are taking their clinical trials to China and Australia. U.S. officials are making moves to keep them at home.
FDA and NIH officials unveiled a package of regulatory tweaks as more companies go elsewhere for drug research.
The Source
TWSJ
Business
Opinion | AI Needs Public Quality Testing
TWSJ·54m ago·3 min read
Tech
Trump Seeks to Boost Quantum Computing With New Executive Orders
TWSJ·27m ago·3 min read
Tech
Oil Prices Drop After Iran Cleared to Sell Crude in Dollars
TWSJ·35m ago·3 min read
Business
Domino’s Picks Veteran Executive to Steer It Through Tough Patch for Pizza
TWSJ·58m ago·3 min read
Related
On this beat
Health
The Hidden Hormone Controlling Your Energy, Mood, And Recovery
AOHL·5h ago·3 min read
Health
Pakistan Plans to Cut Tax on Menstrual Pads, but Many Say It’s Not Enough
TNYT·6h ago·3 min read
Health
Confirmed Ebola cases in Congo top 1,000, deaths surpass 250, officials say
CBS NEWS·9h ago·3 min read
Health
Doctors say that GLP-1 medications can prevent lifelong obesity and Type 2 diabetes in children—but there are some worries
TWSJ·11h ago·3 min read